Pfizer CEO Albert Bourla Buys More Phantom Stock, Signaling Strong Investor Confidence
CEO Albert Bourla buys 20 phantom‑stock units at $29.58—showing long‑term confidence in Pfizer’s oncology pipeline and potential upside for investors.
3 minutes to read